413 related articles for article (PubMed ID: 19469257)
1. [The use of prokinetics for the correction of motor and tonic digestive disorders].
Maev IV; Samsonov AA; Karmanova EA; Ivanchenko EA
Klin Med (Mosk); 2009; 87(3):49-53. PubMed ID: 19469257
[TBL] [Abstract][Full Text] [Related]
2. Pitfalls in designing trials of functional dyspepsia: the ascent and demise of itopride.
Veldhuyzen Van Zanten SJ
Gut; 2008 Jun; 57(6):723-4. PubMed ID: 18477673
[No Abstract] [Full Text] [Related]
3. Prokinetics and fundic relaxants in upper functional GI disorders.
Tack J
Curr Opin Pharmacol; 2008 Dec; 8(6):690-6. PubMed ID: 18940266
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of new gastro-intestinal prokinetic (ENGIP-II) study.
Walwaikar PP; Kulkarni SS; Bargaje RS
J Indian Med Assoc; 2005 Dec; 103(12):708-9. PubMed ID: 16821670
[TBL] [Abstract][Full Text] [Related]
5. [On the possibility of using prokinetics in gastroenterology].
Sheptulin AA; Vize-Khripunova MA
Klin Med (Mosk); 2010; 88(5):19-22. PubMed ID: 21089451
[TBL] [Abstract][Full Text] [Related]
6. Itopride in the treatment of functional dyspepsia in Chinese patients: a prospective, multicentre, post-marketing observational study.
Sun J; Yuan YZ; Holtmann G
Clin Drug Investig; 2011 Dec; 31(12):865-75. PubMed ID: 22035464
[TBL] [Abstract][Full Text] [Related]
7. [Gastrointestinal complications in diabetes mellitus].
Perusicová J
Vnitr Lek; 2004 May; 50(5):338-43. PubMed ID: 15305628
[TBL] [Abstract][Full Text] [Related]
8. Itopride and pantoprazole outcomes in diabetic gastroparesis trial (IPOD trial).
Venkatesh V; Kulkarni KP
J Indian Med Assoc; 2008 Dec; 106(12):814-5. PubMed ID: 19370958
[TBL] [Abstract][Full Text] [Related]
9. [Prokinetic agents--their contribution to practice of gastroenterology].
Hep A; Dolina J
Vnitr Lek; 2011 Sep; 57(9):693-6. PubMed ID: 21957760
[TBL] [Abstract][Full Text] [Related]
10. Development of drugs for gastrointestinal motor disorders: translating science to clinical need.
Sanger GJ; Alpers DH
Neurogastroenterol Motil; 2008 Mar; 20(3):177-84. PubMed ID: 18257767
[TBL] [Abstract][Full Text] [Related]
11. [Use of itopride in the symptoms of functional dyspepsia in Russia: results of a phase IV prospective open-label multicenter clinical trial].
Kas'ianenko VI; Denisov NL; Vasil'ev IuV
Ter Arkh; 2014; 86(8):35-41. PubMed ID: 25306742
[TBL] [Abstract][Full Text] [Related]
12. [Prokinetics and diabetes mellitus].
Keil R
Vnitr Lek; 2004 May; 50(5):358, 360-2. PubMed ID: 15305632
[TBL] [Abstract][Full Text] [Related]
13. [Functional disorders of the digestive tract and possibilities of therapy with Prepulside (cisapride)].
Hep A; Prásek J; Dítĕ P
Vnitr Lek; 1995 Mar; 41(3):199-203. PubMed ID: 7762181
[TBL] [Abstract][Full Text] [Related]
14. [Functional dyspepsia. Itopride improves symptoms].
Kreutzkamp B
Med Monatsschr Pharm; 2006 Oct; 29(10):387-8. PubMed ID: 17058905
[No Abstract] [Full Text] [Related]
15. Effectiveness of prokinetic agents against diseases external to the gastrointestinal tract.
Hiyama T; Yoshihara M; Tanaka S; Haruma K; Chayama K
J Gastroenterol Hepatol; 2009 Apr; 24(4):537-46. PubMed ID: 19220673
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of itopride hydrochloride in patients with non-ulcer dyspepsia.
Shenoy KT; Veenasree ; Leena KB
J Indian Med Assoc; 2003 Jun; 101(6):387-8. PubMed ID: 14579989
[TBL] [Abstract][Full Text] [Related]
17. Ion channels as targets for treatment of gastrointestinal motility disorders.
Farrugia G
Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():135. PubMed ID: 18924455
[No Abstract] [Full Text] [Related]
18. Pharmacology of the new treatments for lower gastrointestinal motility disorders and irritable bowel syndrome.
Camilleri M
Clin Pharmacol Ther; 2012 Jan; 91(1):44-59. PubMed ID: 22071696
[No Abstract] [Full Text] [Related]
19. [Prokinetic agents (prokinetics) in the treatment of motor disorders of the gastrointestinal tract].
Frol'kis AV
Ter Arkh; 1998; 70(2):69-72. PubMed ID: 9551580
[No Abstract] [Full Text] [Related]
20. [Management of gastrointestinal diseases using a motility-regulating preparation. Results of a field study using bromopride (Viaben) conducted by 530 general practitioners on 4182 patients].
Fischer M; Jesau R; Tinhof W
Fortschr Med; 1979 May; 97(18):883-8. PubMed ID: 428853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
